2013British Journal of HaematologyRequires access

Histone deacetylase ( HDAC ) inhibitors as single agents induce multiple myeloma cell death principally through the inhibition of class I HDAC

Sridurga Mithraprabhu, Tiffany Khong, Simon S. Jones, Andrew Spencer

Open publisher page 39 citations

Abstract

The British Journal of Haematology publishes original research papers in clinical, laboratory and experimental haematology. The Journal also features annotations, reviews, short reports, images in haematology and Letters to the Editor.

About this research paper

What this paper is about

The British Journal of Haematology publishes original research papers in clinical, laboratory and experimental haematology. The Journal also features annotations, reviews, short reports, images in haematology and Letters to the Editor.

Why it matters

OpenAlex reports 39 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

The British Journal of Haematology publishes original research papers in clinical, laboratory and experimental haematology. The Journal also features annotations, reviews, short reports, images in haematology and Letters to the Editor.

Key concepts: Histone deacetylase, HDAC11, Multiple myeloma, Histone deacetylase 5, HDAC10, HDAC4, Cancer research, Histone

Related papers

Back to paper searchBrowse research topicsOriginal source
Histone deacetylase ( HDAC ) inhibitors as single agents induce multiple myeloma cell death principally through the inhibition of class I HDAC — Research Paper | ScholarLens